Literature DB >> 334421

Human lymphocyte differentiation markers and their application to immune deficiency and lymphoproliferative diseases.

F P Siegal, R A Good.   

Abstract

The study of human lymphoid cell differentiation markers has recently yielded many insights into the pathogenesis of certain diseases which primarily affect the immune system. The application of these markers has, however, generated a host of new questions. Both technical difficulties and uncertainties concerning the significance of particular markers limit their routine application at the present time. Indeed, many studies in the literature, both in the diseases reviewed above, and perhaps to a greater degree in other conditions ('autoimmune' diseases, sarcoidosis, hepatitis and various infections) require re-evaluation in the light of recently increased sophistication about cell surfaces. Because of these qualificatins, the application of multiple characterizations of lymphoid cells using independent methodologies is necessary before any firm conclusions can be drawn in a particular clinical or experimental situation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 334421

Source DB:  PubMed          Journal:  Clin Haematol        ISSN: 0308-2261


  13 in total

1.  Surface markers in leukemias and lymphomas.

Authors:  F P Siegal; D A Filippa; B Koziner
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

2.  Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; F Rousset; J Pene; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

3.  The capacity of interleukin-4 to induce in vitro IgE synthesis by B cells of patients with common variable immunodeficiency.

Authors:  G Pastorelli; M G Roncarolo; C Peronne; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

4.  Terminal B cell development as seen in different human myelomas and related disorders.

Authors:  G F Burns; C P Worman; B E Roberts; C G Raper; C R Barker; J C Cawley
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

5.  Human B-lymphocyte heteroantigens: direct evidence for specificities not shared by monocytes.

Authors:  D Espinouse; F Touraine; D Schmitt; J L Touraine
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

6.  Induction of immunoglobulin synthesis in corticosteroid-treated blood lymphocytes of a patient with acquired agammaglobulinemia.

Authors:  S D Litwin; A Rubinstein; B Atassi; M Sicklick
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

7.  Antihelper T cell autoantibody in acquired agammaglobulinemia.

Authors:  A Rubinstein; M Sicklick; V Mehra; F S Rosen; R H Levey
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

8.  Immunologic diagnosis and monitoring of human acute leukemias: a review.

Authors:  M Maheu; M A Baker; J A Falk; R N Taub
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

9.  Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency.

Authors:  G Kruger; K Welte; N Ciobanu; C Cunningham-Rundles; P Ralph; S Venuta; S Feldman; B Koziner; C Y Wang; M A Moore
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

10.  Spontaneous mouse erythrocyte-rosette formation: correlation with surface immunoglobulin phenotype in hairy-cell leukaemia.

Authors:  G F Burns; J C Cawley
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.